Conference abstract · 28 Jul 2016
Conference abstractPublished 28 Jul 2016
Autoimmunity and lymphoma
Australian National University, Australia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
When autoimmunity began to emerge as a recognized disease process around 1950s, numerous studies linked several different autoimmune diseases with benign and malignant lympho-proliferative disorders in humans as well as animal models. Cuttner et al have investigated the relationship of prior autoimmune disease to the development of non-Hodgkin's lymphoma (NHL). Patients with NHL (n=278) seen during the 10 years period were compared with the controls, (n=317) seen at the same time. A comparison between these patient groups was performed based on various statistical analysis as well as logistic regression analysis to ascertain the risk of autoimmunity in NHL. 36 (13%) NHL patients had a prior autoimmune disease compared to 5% of controls (p=0.001). 69% of NHL patients with a prior autoimmune disease were female compared to 43% without a prior autoimmune disease and this was similar in control patients, 69% and 48%, respectively. 20% of all women with NHL had a history of autoimmune disease compared to 7% of women in the control group (p=0.001). 19 of the NHL patients with autoimmune disease (56%) received immunosuppressive treatment compared to 5 (38%) in the controls Strength of Association: Existing clinical data on the autoimmunity-lymphoma association are rather meagre because many of the clinical studies have been anecdotal case collections rather than well studied prospective studies 2. However, adequate studies establish strong associations between B cell lymphomas and SjoÃ?Â?gren’s syndrome, autoimmune thyroiditis and autoimmune haemolytic anaemia. Apoptosis: The role of defective apoptosis in the genesis of lymphoproliferation, autoimmunity and lymphoma was dramatically illustrated by the autoimmune lymphoproliferative syndrome (ALPS) of childhood. ALPS is the result of dominant heterozygous inheritance of a mutated (inactive) gene, (NIH), lymphoma occurred in 6 of 46 individuals, 13% of patients, usually long after the onset of ALPS at intervals from 6âÂ?Â?48 years. Sustained Antigen Drive: An example of such mechanism would be the chronic H. pylori infection that drives the host response, with T cell stimulation, ultimately generates an active lympho proliferating in B cell population. The ensuing MALT lymphoma will regress up to a certain point if H. pylori is eradicated. However, acquisition of particular chromosomal translocations among reactive B cells are lymphomogenic. Mutagenicity Among B cells : The third mechanism: B cell mutagenicity. Early B cell developmental events in the bone marrow operate to generate the B cell antigen receptor (BCR). Leading to further diversification of the BCR and developmwnt of lymphoproliferative disorder. Hodgkin’s Disease: Personal history of autoimmune diseases is consistently associated with increased risk of non-Hodgkin’s lymphoma. 6 Recent data also indicate that the risk of HL is increased following autoimmune diseases. 7âÂ?Â?9 Kristinsson et al, recently analyzed the association of a personal history of autoimmune conditions in 7,476 HL patients compared to 18,573 controls, and found several autoimmune conditions to be strongly associated with HL, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), sarcoidosis, and immune thrombocytopenic purpura (ITP). It was found that an overall 2.7-fold increased risk for all systemic autoimmune diseases combined.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 28 Jul 2016
Autoimmune disorders and Lymphoma
Case report · 2018
Case Report of Autoimmune Haemolysis with Lymphoma-Managing the Impossible
Research article · 2017
Relationship between Autoimmune Diseases and Imbalances in Helper/Suppressor T-cell Populations after Rituximab-containing Chemotherapyfor Non-Hodgkin Lymphoma
Case report · 28 Apr 2015
T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Masquerading as Autoimmune Hepatitis with Clinical Features of Hemophagocytic Lymphohistiocytosis
More from this journal
The newest in Immunotherapy: Open Access.
Perspective · 19 Mar 2025
Understanding the Immune Response to Checkpoint Inhibitors in Immunotherapy
Perspective · 19 Mar 2025
Advancing Immunotherapy: Future Directions in the Fight against Renal Cell Carcinoma
Short communication · 19 Mar 2025
Emerging Therapies: The Latest Developments in Autoimmune Disease Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalImmunotherapy: Open Access
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Nalini Pati”

